Vertebral Body Sparing Craniospinal Irradiation for Pediatric Patients With Cancer of the Central Nervous System
Completed · Not applicable
Conditions studied: Malignant Central Nervous System Neoplasm
In brief
This trial studies the feasibility of using intensity modulated proton therapy to deliver craniospinal irradiation while avoiding the bones of the vertebral column. Intensity modulated proton therapy is an advanced radiation therapy modality that uses high energy protons to kill cancer cells and shrink tumors, and may reduce the side effects of treatment by reducing radiation exposure to the spinal column.
Key facts
- Study ID
- NCT04276194
- Run by
- Emory University
- People needed
- 10
- Starts
- 2019-12-16
- Expected to finish
- 2024-02-09
- Last updated by the study team
- 2024-03-21
Who can join
Age: 3 and older, up to 18. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Pathologic diagnosis of central nervous system malignancy requiring craniospinal irradiation.
- Signed informed consent and assent when indicated.
You may not qualify if…
- Any contraindication to undergoing MRI (ferromagnetic implants such as aneurysm clips, surgical clips, prostheses, artificial cardiac valves or devices, electrical implants such as cardiac pacemakers or perfusion pumps). Metal fragments, shrapnel, or tattoos near the eye.
- Any major uncontrolled or poorly controlled current illness that would limit compliance with study requirements.
- Pregnant females are excluded. Females of childbearing age/menstruating must confirm that either they are not sexually active or have a negative pregnancy test prior to initiation of radiation therapy.
Where it is running
- Emory Proton Therapy Center — Atlanta, Georgia, United States
- Emory University Hospital/Winship Cancer Institute — Atlanta, Georgia, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.